These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 18208933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G, Redman J.
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [Abstract] [Full Text] [Related]

  • 3. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C, Fisk JE.
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

  • 10. Is emotional intelligence impaired in ecstasy-polydrug users?
    Craig L, Fisk JE, Montgomery C, Murphy PN, Wareing M.
    J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
    [Abstract] [Full Text] [Related]

  • 11. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A.
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 17. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL, Shear PK, Corcoran K.
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [Abstract] [Full Text] [Related]

  • 18. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 19. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.